281 related articles for article (PubMed ID: 8163673)
1. Antibodies to opacity proteins (Opa) correlate with a reduced risk of gonococcal salpingitis.
Plummer FA; Chubb H; Simonsen JN; Bosire M; Slaney L; Nagelkerke NJ; Maclean I; Ndinya-Achola JO; Waiyaki P; Brunham RC
J Clin Invest; 1994 Apr; 93(4):1748-55. PubMed ID: 8163673
[TBL] [Abstract][Full Text] [Related]
2. Antibody to Rmp (outer membrane protein 3) increases susceptibility to gonococcal infection.
Plummer FA; Chubb H; Simonsen JN; Bosire M; Slaney L; Maclean I; Ndinya-Achola JO; Waiyaki P; Brunham RC
J Clin Invest; 1993 Jan; 91(1):339-43. PubMed ID: 8423230
[TBL] [Abstract][Full Text] [Related]
3. Gonococcal salpingitis is less likely to recur with Neisseria gonorrhoeae of the same principal outer membrane protein antigenic type.
Buchanan TM; Eschenbach DA; Knapp JS; Holmes KK
Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 2):978-80. PubMed ID: 6781350
[TBL] [Abstract][Full Text] [Related]
4. [Clinical laboratory studies in acute chlamydial, gonococcal and nonchlamydial nongonococcal salpingitis].
Karadzhova R; Borisov I; Kalfin E; Marinova M; Neĭkova V; Tsoneva V
Akush Ginekol (Sofiia); 1992; 31(1):16-7. PubMed ID: 1342144
[TBL] [Abstract][Full Text] [Related]
5. Douching, pelvic inflammatory disease, and incident gonococcal and chlamydial genital infection in a cohort of high-risk women.
Ness RB; Hillier SL; Kip KE; Richter HE; Soper DE; Stamm CA; McGregor JA; Bass DC; Rice P; Sweet RL
Am J Epidemiol; 2005 Jan; 161(2):186-95. PubMed ID: 15632269
[TBL] [Abstract][Full Text] [Related]
6. Infections with Neisseria gonorrhoeae and Chlamydia trachomatis in women with acute salpingitis.
Kristensen GB; Bollerup AC; Lind K; Mårdh PA; Ladehoff P; Larsen S; Marushak A; Rasmussen P; Rolschau J; Skoven I
Genitourin Med; 1985 Jun; 61(3):179-84. PubMed ID: 3924816
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to Chlamydia trachomatis, Mycoplasma hominis, and Neisseria gonorrhoeae in sera from patients with acute salpingitis.
Märdh PA; Lind I; Svensson L; Weström L; Møller BR
Br J Vener Dis; 1981 Apr; 57(2):125-9. PubMed ID: 6783261
[TBL] [Abstract][Full Text] [Related]
8. Gonococcal opacity protein promotes bacterial entry-associated rearrangements of the epithelial cell actin cytoskeleton.
Grassmé HU; Ireland RM; van Putten JP
Infect Immun; 1996 May; 64(5):1621-30. PubMed ID: 8613370
[TBL] [Abstract][Full Text] [Related]
9. Characterization of gonococcal antigens responsible for induction of bactericidal antibody in disseminated infection.
Rice PA; Kasper DL
J Clin Invest; 1977 Nov; 60(5):1149-58. PubMed ID: 409733
[TBL] [Abstract][Full Text] [Related]
10. Selection for a CEACAM receptor-specific binding phenotype during Neisseria gonorrhoeae infection of the human genital tract.
Sintsova A; Wong H; MacDonald KS; Kaul R; Virji M; Gray-Owen SD
Infect Immun; 2015 Apr; 83(4):1372-83. PubMed ID: 25605771
[TBL] [Abstract][Full Text] [Related]
11. The occurrence of chlamydial and gonococcal salpingitis during the menstrual cycle.
Sweet RL; Blankfort-Doyle M; Robbie MO; Schacter J
JAMA; 1986 Apr; 255(15):2062-4. PubMed ID: 3959289
[TBL] [Abstract][Full Text] [Related]
12. Antibody to reduction modifiable protein increases the bacterial burden and the duration of gonococcal infection in a mouse model.
Gulati S; Mu X; Zheng B; Reed GW; Ram S; Rice PA
J Infect Dis; 2015 Jul; 212(2):311-5. PubMed ID: 25596304
[TBL] [Abstract][Full Text] [Related]
13. Analysis of antibodies in local and disseminated Neisseria gonorrhoeae infections by means of gel electrophoresis-derived ELISA.
Hadfield SG; Glynn AA
Immunology; 1982 Oct; 47(2):283-8. PubMed ID: 6811421
[TBL] [Abstract][Full Text] [Related]
14. [The therapeutic efficacy of a gonococcal vaccine].
Andreeva ZM; Bednova VN; Shevchenko NM; Malyshev AM; Danilenko TI
Vestn Dermatol Venerol; 1989; (11):53-5. PubMed ID: 2515676
[TBL] [Abstract][Full Text] [Related]
15. Gonococcal infection: a model of molecular pathogenesis.
Britigan BE; Cohen MS; Sparling PF
N Engl J Med; 1985 Jun; 312(26):1683-94. PubMed ID: 2860565
[No Abstract] [Full Text] [Related]
16. Serologic investigation of the immune response in various types of gonogoccal infection.
Danielsson D; Thyresson N; Falk V; Barr J
Acta Derm Venereol; 1972; 52(6):467-75. PubMed ID: 4118393
[No Abstract] [Full Text] [Related]
17. Human immunity to Neisseria gonorrhoeae: acquired serum opsonic antibodies.
Bisno AL; Ofek I; Beachey EH; Chandler RW; Curran JW
J Lab Clin Med; 1975 Aug; 86(2):221-9. PubMed ID: 807662
[TBL] [Abstract][Full Text] [Related]
18. Gonococcal and nongonococcal arthritis.
García-De La Torre I; Nava-Zavala A
Rheum Dis Clin North Am; 2009 Feb; 35(1):63-73. PubMed ID: 19480997
[TBL] [Abstract][Full Text] [Related]
19. Serum antibody response to the 70,000-molecular-weight neisserial common antigen in humans infected by Neisseria gonorrhoeae.
Aoun L; Cremieux AC; Casin I; Morel P; Martin PM
J Clin Microbiol; 1988 Sep; 26(9):1898-900. PubMed ID: 3141472
[TBL] [Abstract][Full Text] [Related]
20. Ligation of cell surface heparan sulfate proteoglycans by antibody-coated beads stimulates phagocytic uptake into epithelial cells: a model for cellular invasion by Neisseria gonorrhoeae.
Dehio C; Freissler E; Lanz C; Gómez-Duarte OG; David G; Meyer TF
Exp Cell Res; 1998 Aug; 242(2):528-39. PubMed ID: 9683539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
